Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magda Conway

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|May 20, 2022
Health Equity in Pediatric Drug Development: Translating Aspiration into OperationMorenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, et al.
The Lancet. Global Health|March 28, 2025
Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practiceNina Gobat, Catherine Slack, Stacey Hannah, et al.
Contemporary Clinical Trials|April 18, 2024
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 yearsAnna Turkova, Man K Chan, Cissy Kityo, et al.
The Lancet. HIV|April 10, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trialAdeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|May 20, 2022
Health Equity in Pediatric Drug Development: Translating Aspiration into OperationMorenike Oluwatoyin Folayan, Magda Conway, Carolyn Russo, et al.
The Lancet. Global Health|March 28, 2025
Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practiceNina Gobat, Catherine Slack, Stacey Hannah, et al.
Contemporary Clinical Trials|April 18, 2024
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 yearsAnna Turkova, Man K Chan, Cissy Kityo, et al.
The Lancet. HIV|April 10, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trialAdeodata R Kekitiinwa, Angus Jennings, Mutsa Bwakura-Dangarembizi, et al.
Pageof 1